announces

SGX Pharmaceuticals Announces Strategic Collaboration To Develop And Commercialize BCR-ABL Inhibitor

Under the terms of the agreement, SGX will receive from Novartis $25 million in upfront payments and the purchase of SGX common stock. Along with success-based milestones, but excluding royalties, total payments to SGX could exceed $515 million, including a minimum of two years of research funding.
The success of Gleevec(TM) (imatinib), the first targeted therapy [...]

Posted in | Tagged , , , , , , , , , , | Leave a response

Blackboard Inc. Announces 2006 and 2007 Financial Guidance

Blackboard’s operating results will incorporate the results of operations for WebCT from March 1, 2006 and will be subject to a preliminary allocation of purchase price and other purchase accounting adjustments to the February 28, 2006 opening balance sheet.
Outlook for the First Quarter and Full Year 2006
The Company’s guidance for the first quarter of 2006 [...]

Posted in | Tagged , , , , , , , | Leave a response